Merck Foundation's five-year plan to close diabetes care disparity gap

9 March 2009

The Merck Company Foundation, the philanthropic arm of US drug major  Merck & Co, has announced the launch of The Alliance to Reduce  Disparities in Diabetes, a new initiative designed to improve health  care delivery among those populations most at risk - African-Americans,  Hispanics and Native American adults. The US Department of Health and  Human Services' Centers for Disease Control and Prevention (CDC) and the  Office of Minority Health joined the Foundation in support of the  Alliance's goal to mobilize community-based partners and enhance the  delivery of proven, collaborative approaches that can close gaps in  diabetes care.

Research shows insufficient health resources, poor disease management,  inadequate patient education and support, as well as individual  perceptions about how difficult it is to manage and prevent diabetes all  contribute to health care disparities. These problems are more acute in  low-income, disadvantaged communities. The initiative will engage a  range of health care stakeholders, including patients, providers and  health system leaders, to assist at the grassroots level in five US  communities and mobilize allies at the national and state levels.

Becoming a mobilizing force

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



More ones to watch >




Today's issue

Company Spotlight